{
  "slug": "breaking-into-hiv-1-s-epigenetic-vault-cure-strategies-to-elim-41902262",
  "source": {
    "title": "Breaking into HIV-1's Epigenetic Vault: Cure Strategies to Eliminate the Viral Reservoir.",
    "journal": "Viruses",
    "year": 2026,
    "doi": "10.3390/v18030354",
    "pmid": "41902262",
    "content_access_status": "FULL_TEXT_OA"
  },
  "claims": [
    {
      "statement": "HIV-1 integrates into host-cell DNA as a provirus.",
      "epistemic_type": "EVIDENCE",
      "evidence_level": "D",
      "confidence": "100",
      "evidence_excerpt": "Human immunodeficiency virus type 1 (HIV-1) is a retrovirus that integrates into the host cell's DNA as a provirus.",
      "review_status": "PASSED"
    },
    {
      "statement": "HIV-1 proviral transcription is regulated largely by cellular proteins and epigenetic factors.",
      "epistemic_type": "EVIDENCE",
      "evidence_level": "D",
      "confidence": "100",
      "evidence_excerpt": "Transcription from the provirus is regulated in large part by cellular proteins and epigenetic factors.",
      "review_status": "PASSED"
    },
    {
      "statement": "The reviewed HIV-1 cure strategies include Shock and Kill and Block and Lock approaches that target proviral chromatin states.",
      "epistemic_type": "EVIDENCE",
      "evidence_level": "D",
      "confidence": "100",
      "evidence_excerpt": "Indeed, proviral chromatin is the focus of two of the current HIV-1 cure strategies. \"Shock and Kill\" uses latency reversal agents to open the provirus's chromatin, promoting high levels of gene expression that induce the killing of infected cells. \"Block and Lock\" uses latency promoting agents to induce heterochromatin, blocking transcription and forcing HIV-1 into a state of deep latency.",
      "review_status": "NEEDS_HUMAN"
    },
    {
      "statement": "The article reviews compounds investigated in HIV-1 Shock and Kill and Block and Lock strategies, including mechanisms of action and clinical results.",
      "epistemic_type": "EVIDENCE",
      "evidence_level": "D",
      "confidence": "100",
      "evidence_excerpt": "Here, the compounds investigated in both strategies are reviewed, including their chemical structures, mechanisms of action, and clinical results.",
      "review_status": "PASSED"
    },
    {
      "statement": "The provided source does not report FeLV-specific evidence for epigenetic cure strategies.",
      "epistemic_type": "OPEN_QUESTION",
      "evidence_level": null,
      "confidence": "100",
      "evidence_excerpt": null,
      "review_status": "NEEDS_HUMAN"
    }
  ],
  "provenance": {
    "agent": "AVAPROJECT-VIROLOGY-001",
    "critic": "AVAPROJECT-CRITIC-001",
    "model": "openai-codex",
    "updated": "2026-08-31 19:46 UTC",
    "updated_iso": "2026-08-31T19:46:57Z"
  }
}